Qingdao Haier Biomedical Co., Ltd was established in October 2005, starting with the research, development, production and sales of biomedical equipment for low temperature storage. It is a comprehensive biological solution provider based on IoT transformations. Oriented to the global market, Haier Biomedical mainly provides low temperature storage solutions for usage scenarios like biobanks, blood safety, vaccine safety, medicine and reagent safety, then takes the lead in IoT integration and innovation, and strives to provide IoT based comprehensive biological solutions for the pain points in usage scenarios stated above.
It has broken the overseas monopolization and made breakthrough in low temperature technology, and manages to provide the low temperature storage equipment with full temperature range between -196℃ and 8℃. It is also the first and only company in the industry that has won the second prize of National Science and Technology Progress Award. The number of US Energy Star certifications obtained by the company ranks first in the world, leading a revolution of energy-saving and high-efficiency in the industry.
On the basis of achieving technology industrialization, the company has realized global expansion, whose products have been supplied to more than 100 countries and regions in the world and market position is NO.1 among all the Chinese brands. At present, the company integrates and innovates the IoT technology and biomedical low temperature storage technology, realizing iterative upgrading from electrical appliances to network appliances and from usage scenarios to ecology.
|Full name||Qingdao Haier biomedical Co., Ltd|
|Domicile||Haier Industrial Park, Economic and Technological development zone, Qingdao|
|Has weighted voting rights structure?||No|
|Earnings Per Share||0.56||0.35||0.72|
|R&D expenditure as a % of operating revenue||10.74%||13.34%||7.40%|
|Total Owners' Equity||1,113.75||614.76||722.81|
|Net Cash Flows-Operating||149.00||148.32||220.72|
|Net Cash Flows-Investing||-763.97||-114.08||-423.31|
|Net Cash Flows-Financing||826.23||-||-|
|Name||No. of Shares Held (mn)||% of Shares Held|
|Qingdao Haier biomedical Co., Ltd||10.0591463||31.73%|
|Shanghai JunHeLiCheng Investment Management Center（limited partnership）－Ningbo Meishan Bonded Port Area Qijun Equity Investment Partnership (Limited Partnership)||6.4207317||20.25%|
|Qingdao HaiZhiHuiYing Equity Investment Management Co., Ltd－Qingdao HaiChuangRui Equity Investment Fund Center （limited partnership）||3.2103659||10.13%|
|Tianjin HaiYingKang Corporation Management Partnership（limited partnership）||1.2261689||3.87%|
|Tianjin HaiChuangYingKang Corporation Management Partnership（limited partnership）||1.1517739||3.63%|
|China National Pharmaceutical Co., Ltd||0.8989024||2.84%|
|CUFE LONG MA CAPITAL－Ningbo Meishan Bonded Port Area Long Hui He Cheng Equity Investment Partnership (Limited Partnership)||0.8132927||2.57%|
|GUOTAI JUNAN ZHENGYU INVESTMENT||0.3170718||1.00%|
|China construction bank co. LTDCorporation pension plan- Industrial and commercial bank of China LTD||0.172104||0.05%|
|PetroChina Corporation pension plan- Industrial and commercial bank of China LTD||0.145739||0.05%|
|SINOPEC Corporation pension plan- Industrial and commercial bank of China LTD||0.145739||0.05%|
All information contained herein is provided by the underlying company itself and is for informational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. The Shanghai Stock Exchange does not guarantee its accuracy and reliability and shall under no circumstance be responsible or liable for any error or for any loss directly or indirectly arising from any inaccuracy or omission or from any decision, action or non-action based on or in reliance upon the information herein.
Users may view and download the information herein for personal and non-commercial use free of charge subject to the laws of the People's Republic of China and the Legal Statement. No part of the information herein may be copied, downloaded, stored in a retrieval system or transmitted in any form or by any means, rented, displayed, performed, reproduced, photocopied, altered, sold, broadcast, published or otherwise in whole or in part in any manner for commercial purposes, without the prior written consent of the Shanghai Stock Exchange.
Users are hereby reminded that the Legal Statement represents your legally binding agreement with the Shanghai Stock Exchange. By accessing or using this website, you are also signifying your agreement with and acceptance of all the contents in the Legal Statement. The Shanghai Stock Exchange reserves the right to amend and interpret the Legal Statement.